BENJAMIN WOLF is a senior associate in the Health Care Group and a member of the Food, Drug & Device/FDA Team at Alston & Bird LLP. He counsels clients in many industries regulated by the Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA). He has particular interest and experience in medical devices and agency compliance action, as well as the regulation of food, beverages, animal feed, dietary supplements, and tobacco products. In his role in industry, Mr. Wolf developed medical devices, assisted with regulatory applications, and worked to address regulators’ questions. At the FDA, he reviewed product applications, conducted inspections, and developed policies for submission review, inspections, recalls, and other post-market issues with focuses on medical devices, combination products, and tobacco (including e-cigarettes). In private practice, Mr. Wolf has worked extensively in prominent FDA regulatory firms on matters involving tobacco, food, animal feed, dietary supplements, cannabis, and cannabidiol (CBD) products. Since March, he has been advising companies on matters related to COVID-19.